Similar articles

• Leigh syndrome is the main clinical characteristic of PTCD3 deficiency.

  Muñoz-Pujol G, Ortigoza-Escobar JD, Paredes-Fuentes AJ, Jou C, Ugarteburu O, Gort L, Yubero D, García-Cazorla A, O'Callaghan M, Campistol J, Muchart J, Yépez VA, Gusic M, Gagneur J, Prokisch H, Artuch R, Ribes A, Urreizti R, Tort F. Muñoz-Pujol G, et al. Brain Pathol. 2023 May;33(3):e13134. doi: 10.1111/bpa.13134. Epub 2022 Nov 30. Brain Pathol. 2023. PMID: 36450274 Free PMC article.
• Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome.

  Borna NN, Kishita Y, Kohda M, Lim SC, Shimura M, Wu Y, Mogushi K, Yatsuka Y, Harashima H, Hisatomi Y, Fushimi T, Ichimoto K, Murayama K, Ohtake A, Okazaki Y. Borna NN, et al. Neurogenetics. 2019 Mar;20(1):9-25. doi: 10.1007/s10048-018-0561-9. Epub 2019 Jan 3. Neurogenetics. 2019. PMID: 30607703
• Leigh-like syndrome due to OPA1 mutations.

  Finsterer J, Zarrouk-Mahjoub S. Finsterer J, et al. Eur J Paediatr Neurol. 2017 Nov;21(6):921-922. doi: 10.1016/j.ejpn.2017.06.006. Epub 2017 Jul 5. Eur J Paediatr Neurol. 2017. PMID: 28711503 No abstract available.
• Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options.

  Gerards M, Sallevelt SC, Smeets HJ. Gerards M, et al. Mol Genet Metab. 2016 Mar;117(3):300-12. doi: 10.1016/j.ymgme.2015.12.004. Epub 2015 Dec 19. Mol Genet Metab. 2016. PMID: 26725255 Review.
• Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy.

  Wang SB, Weng WC, Lee NC, Hwu WL, Fan PC, Lee WT. Wang SB, et al. Pediatr Neonatol. 2008 Aug;49(4):145-9. doi: 10.1016/S1875-9572(08)60030-3. Pediatr Neonatol. 2008. PMID: 19054921 Review.